|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-10-25
|
|
pubmed:abstractText |
Lamivudine-induced hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B was reported to be durable by several studies but controversy still exists. The aim of this study was to evaluate the durability of the responses of lamivudine treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 European Association for the Study of the Liver
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
669-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12399235-Acute Disease,
pubmed-meshheading:12399235-Adolescent,
pubmed-meshheading:12399235-Adult,
pubmed-meshheading:12399235-Alanine Transaminase,
pubmed-meshheading:12399235-Female,
pubmed-meshheading:12399235-Follow-Up Studies,
pubmed-meshheading:12399235-Hepatitis B, Chronic,
pubmed-meshheading:12399235-Hepatitis B Antibodies,
pubmed-meshheading:12399235-Hepatitis B e Antigens,
pubmed-meshheading:12399235-Humans,
pubmed-meshheading:12399235-Lamivudine,
pubmed-meshheading:12399235-Male,
pubmed-meshheading:12399235-Middle Aged,
pubmed-meshheading:12399235-Predictive Value of Tests,
pubmed-meshheading:12399235-Recurrence,
pubmed-meshheading:12399235-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation.
|
|
pubmed:affiliation |
Liver Unit, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. chmolee@ms15.hinet.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
